Mutation detail:
| Mutation site | V292I |
| Virus | Influenzavirus A H1N1 |
Mutation level  |
Amino acid Level |
| Gene/protein/region type | PB2 |
| Gene ID | 23308131 |
| Country | - |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | GQ377076.1 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Polymerase PB2 |
| Uniprot protein ID | C3W5X5 |
| Protein length | 759 amino acids |
| Protein description | PB2 plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Recognizes and binds the 7-methylguanosine-containing cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by the viral protein PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex. |
Literature information:
| Pubmed ID | 21094080 |
| Clinical information | No |
| Disease | - |
| Published year | 2011 |
| Journal | J Clin Virol |
| Title | Investigation of causes of oseltamivir chemoprophylaxis failures during influenza A (H1N1-2016) outbreaks |
| Author | Vernon J Lee,Jonathan Yap,Sebastian Maurer-Stroh,Raphael T C Lee,Frank Eisenhaber |
| Evidence | From the whole genome sequencing, several mutations at the HA (T220S, E275V, T333A, D240G);PB2 (K660R, L607V, V292I);NS1 (F103S), and NP (W104G) gene segments were detected, but none of them were likely to result in anti-viral resistance. |